"From 8 a.m. to 2 p.m. on Wednesday, Oct. 21, W. Jones Street downtown will be closed between Wilmington St. and Salisbury St ...

Nearly one in three adults who were still smoking or vaping after a prior ORCA trial had quit at the end of a year of ...

Roivant Sciences' (ROIV) brepocitinib achieved its primary endpoint, along with key secondary endpoints, in two phase 3 trials of non-infectious uveitis, the company said Wednesda ...

NVIDIA today announced collaborations with leading global healthcare and research organizations to advance protein design - including through a newly released open model, RFD4-Proteina - accelerate ...

The American Academy of Science and Letters analyzed 443,543 dissertations over 65 years, looking at how the numbers changed ...

Staunton plans to seek public input as it considers future uses for Staunton Crossing, including advanced manufacturing. Yes, data centers were talked about.

ABU DHABI, 21st October, 2026 (WAM) -- In the presence of H.H. Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes’ Affairs, the ...

Doha: The University of Doha for Science and Technology (UDST), through its College of Health Sciences, has introduced the ...

On October 20, 2026, OpenAI announced it is acquiring Orchestra Bio, a startup that automates workflow management for drug ...

OpenAI has acquired Orchestra Bio, a company whose platform coordinates drug development work across biopharma teams, and is ...

Wave Life Sciences stock is up 8% today at $3.42. The company is also holding a virtual Research Day to present new data.

OpenAI has acquired Orchestra Bio, a platform that helps biopharma teams work with artificial intelligence agents to coordinate drug development. The deal comes amid OpenAI's broader push into the ...